Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP618869.RAtnhAOL7HWVhlj-Ogh9x_MgpcB6i08NpYWI2zGslwrxU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP618869.RAtnhAOL7HWVhlj-Ogh9x_MgpcB6i08NpYWI2zGslwrxU130_assertion type Assertion NP618869.RAtnhAOL7HWVhlj-Ogh9x_MgpcB6i08NpYWI2zGslwrxU130_head.
- NP618869.RAtnhAOL7HWVhlj-Ogh9x_MgpcB6i08NpYWI2zGslwrxU130_assertion description "[We examined the expression levels of mRNA for multidrug resistance 1 (MDR1), multidrug resistance-associated protein (MRP), human canalicular multispecific organic anion transporter (cMOAT), lung resistance-related protein (LRP), topoisomerase IIalpha, beta (Topo IIalpha, beta) and topoisomerase I (Topo I) genes in human head and neck squamous cell carcinoma (HNSCC) specimens and mucosa (HNM) specimens, to elucidate their roles in relation to the biological characteristics and drug resistance in vivo.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP618869.RAtnhAOL7HWVhlj-Ogh9x_MgpcB6i08NpYWI2zGslwrxU130_provenance.
- NP618869.RAtnhAOL7HWVhlj-Ogh9x_MgpcB6i08NpYWI2zGslwrxU130_assertion evidence source_evidence_literature NP618869.RAtnhAOL7HWVhlj-Ogh9x_MgpcB6i08NpYWI2zGslwrxU130_provenance.
- NP618869.RAtnhAOL7HWVhlj-Ogh9x_MgpcB6i08NpYWI2zGslwrxU130_assertion SIO_000772 10744048 NP618869.RAtnhAOL7HWVhlj-Ogh9x_MgpcB6i08NpYWI2zGslwrxU130_provenance.
- NP618869.RAtnhAOL7HWVhlj-Ogh9x_MgpcB6i08NpYWI2zGslwrxU130_assertion wasDerivedFrom befree-20150227 NP618869.RAtnhAOL7HWVhlj-Ogh9x_MgpcB6i08NpYWI2zGslwrxU130_provenance.
- NP618869.RAtnhAOL7HWVhlj-Ogh9x_MgpcB6i08NpYWI2zGslwrxU130_assertion wasGeneratedBy ECO_0000203 NP618869.RAtnhAOL7HWVhlj-Ogh9x_MgpcB6i08NpYWI2zGslwrxU130_provenance.